MAR 16, 2015 10:34 AM PDT

CT Scan Slightly Edges Out Functional Tests for Heart Disease

WRITTEN BY: Judy O'Rourke
Patients with symptoms of heart disease have similar outcomes in terms of death and major cardiac conditions regardless of whether they undergo a functional stress test or a computed tomographic scan, but the scan may be better at ruling out the need for subsequent tests and procedures in patients who are free of heart disease, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.

The PROMISE trial is the first-ever randomized controlled trial to compare clinical outcomes in patients receiving functional stress testing or computed tomographic angiography to check for signs of cardiovascular disease. It also provides the first data to inform clinical guidelines on the use of these tests, according to the authors.

The study included a total of 10,003 patients who visited 193 health centers in the United States and Canada. Participants had no prior diagnosis of coronary artery disease but had new symptoms that made physicians suspect they might have heart disease. Nearly all had at least one cardiovascular risk factor such as high blood pressure, diabetes or a history of smoking.

Half were randomly selected to receive a heart CT scan, which generates 3-D images of the heart's arteries that doctors can use to assess the degree of narrowing. The rest received a functional test-either an exercise electrocardiogram, stress echocardiography or nuclear stress test-which are used to track the heart's response to stress using electrical signals, sound waves or imaging. All of these tests have been in common use for a decade or more but functional tests and CT scans have never before been compared head-to-head in terms of clinical outcomes.

The study showed no differences between patients receiving a heart CT scan and those receiving functional heart tests in terms of the study's primary endpoint, a composite rate of death, heart attack, major procedural complications, or hospitalization for chest pain. At least one of these outcomes occurred in roughly three percent of patients in both groups during more than two years of follow-up.

However, some secondary endpoints, including the level of radiation exposure and the rate of subsequent procedures that did not reveal significant heart disease, favored computed tomographic angiography.

Authors said these results are important because current clinical guidelines leave the selection of tests for patients reporting symptoms such as chest pain or shortness of breath-which constitutes at least 4 million patients in the United States each year-largely up to physician and patient preference.

"Until this study, we have essentially been guessing on decisions about which initial test to use for this huge population of patients who need evaluation for cardiovascular symptoms," says Pamela Douglas, MD, the Ursula Geller Professorship for Research in Cardiovascular Diseases, Duke University, and the study's lead author. "Our study shows that the prognostic outcomes are excellent and are similar regardless of what type of test you use, but there are some indications that computed tomographic angiography might be the safer test with fewer catheterizations without obstructive disease and lower radiation exposure when compared to nuclear testing."

A key strength of the study is that it offers a reflection of current medical practice, rather than an idealized view.

"Unlike most trials where medical care is very tightly controlled, this study was designed to represent real world care," Douglas says. "The health centers that collected the data were responsible for interpreting the tests and doing appropriate patient follow-up. Because this was such a community-based, real-world setting, the study really tells us a lot about clinical practice and how patients are being cared for in the US now."

The 3 percent rate of death, heart attack, major procedural complications or hospitalization for chest pain seen in both groups was lower than expected, especially considering the fact that most study participants had two or more significant heart disease risk factors, were middle aged or older, and symptomatic. The relative benefit of CT angiography compared to functional testing held steady across different patient subgroups as defined by age, gender, race, and cardiovascular risk factors. Although there was a significantly lower rate of death and nonfatal heart attacks after one year of follow-up in patients receiving a heart CT scan, for reasons that are unclear, this difference was not sustained in the second year, study authors said.

"The event rate in itself is intriguing, because no previous studies have closely tracked and adjudicated the rate of adverse events in this patient population," Douglas says. "These outcomes are so good given widespread use of medications like statins and aspirin. It does raise the question of whether we can identify a group of people who actually do not need to be tested."

Douglas says the bottom line for patients is that if the primary concern is avoiding serious adverse heart problems such as death, heart attack, or hospitalization, heart CT scans and functional tests are both excellent options. For lower-priority concerns such as avoiding subsequent tests and procedures or avoiding radiation exposure, heart CT scans appear to be a slightly better option.

The research team also analyzed the financial implications of the data in terms of medical costs and reimbursements, which will be presented separately. The study was simultaneously published online in the New England Journal of Medicine at the time of presentation.

[Source: American College of Cardiology]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
JAN 14, 2021
Cardiology
Cortisol in Your Hair Could Predict Your Risk of Heart Attack
JAN 14, 2021
Cortisol in Your Hair Could Predict Your Risk of Heart Attack
The everyday tracking of health has become far easier these days with the advent of fitness watches and other technology ...
FEB 24, 2021
Cardiology
Drinking Lots of Unfiltered Coffee May Raise Heart Disease Risk
FEB 24, 2021
Drinking Lots of Unfiltered Coffee May Raise Heart Disease Risk
While there has been a lot of debate about whether or not coffee is good for you, a new study reported in Clinical Nutri ...
APR 13, 2021
Cardiology
Can a Ketosis Metabolite Act as a Biomarker for Cardiovascular Diseases?
APR 13, 2021
Can a Ketosis Metabolite Act as a Biomarker for Cardiovascular Diseases?
Quick and reliable diagnostics are the key to controlling many diseases, including cardiovascular disease. Biomarkers ar ...
JUL 07, 2021
Cardiology
Wealth Changes Linked to Heart Health Differences
JUL 07, 2021
Wealth Changes Linked to Heart Health Differences
Changes in a person's financial state have been recognized as a major cause of stress . Now researchers have found inves ...
JUL 12, 2021
Drug Discovery & Development
Testosterone Supplements Reduce Heart Attack and Stroke Risk
JUL 12, 2021
Testosterone Supplements Reduce Heart Attack and Stroke Risk
Taking testosterone supplements significantly reduces risk of heart attack and stroke among men with low levels of the h ...
JUL 16, 2021
Technology
Echocardiogram May Help Predict COVID-19 Patients at Risk for Heart Complications
JUL 16, 2021
Echocardiogram May Help Predict COVID-19 Patients at Risk for Heart Complications
Researchers learned early on in the pandemic that COVID-19 infections caused a range of complications throughout the bod ...
Loading Comments...